12 Papers
27 Citations
M. Wang is an academic researcher from Peking Union Medical College Hospital. The author has contributed to research in topics: Medicine & Internal medicine. The author has an hindex of 4, co-authored 8 publications.
Chat about Author
Papers
AURA17 study of osimertinib in Asia-Pacific patients (pts) with EGFR T790M-positive advanced non-small cell lung cancer (NSCLC): Updated phase II results including overall survival (OS)
C. Zhou,M. Wang,Y. Cheng,Y. Chen,Yufen Zhao,Yuankai Shi,Myung-Ju Ahn,Yilu Lu,M. Shi,J-Y. Han,S. W. Kim,Helong Zhang,G. Chen,H. Li,Jia Wang,Y-L. Wu +15 more
22
1263P Tislelizumab + chemotherapy vs chemotherapy alone as first-line treatment for locally advanced/metastatic nonsquamous NSCLC
Shun Lu,Yang Yu,Xianjun Yu,Yali Hu,Zhiyong Ma,Xifei Li,Wu Zhuang,Y. Liu,Wei Li,Jiuwei Cui,Dawei Wang,Wangjun Liao,M. Wang,Jiaojiao Zhou,Z. Wang,Yihua Sun,Jing Gao,Y. Bao,Li Liang,J. Wang +19 more
10
OA10.07 Resistance Mechanisms of Osimertinib in Chinese Non-Small Cell Lung Cancer patients: Analysis from AURA17 Trial
C. Zhou,Min Hu,Xuehua Zhu,Yihua Sun,Xuesong Lu,Jia Wang,M. Wang,Ying Cheng,Y. Chen,Yizhuo Zhao,Yuankai Shi,Yilu Lu,M. Shi,Henghui Zhang,X. Huang,Zhen Wang,Z. Ding,H. Li,G. Chen,Y-L. Wu +19 more
6
RETRACTED: ORIENT-3: A randomized, open-label, phase III study of sintilimab versus docetaxel in previously treated advanced/metastatic squamous non-small cell lung cancer (sqNSCLC)
Yuankai Shi,Lingqian Wu,Xianjun Yu,Puyuan Xing,Jiaojiao Zhou,A. Wang,Jufang Shi,Yali Hu,Zhenghang Wang,Guangyu An,Yong Fang,Sanyuan Sun,C. Zhou,C. Wang,Feng Ye,Xifei Li,J. Wang,M. Wang,Y. Liu,Yufen Zhao +19 more
TL;DR: The authors of this abstract have advised that full agreement between authors and sponsors on publication of the abstract has not been reached and they are therefore unable to publish this data at present.
5